• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱导的磷酸化及其基于人工智能和机器学习的药物治疗。

SARS-CoV-2-induced phosphorylation and its pharmacotherapy backed by artificial intelligence and machine learning.

作者信息

Qamar Fouzia, Sharif Zubair, Idrees Jawaria, Wasim Asif, Haider Sana, Salman Saad

机构信息

Department of Biology, Lahore Garrison University, Lahore-54000, Punjab, Pakistan.

Faculty of Medical Laboratory Sciences, Superior University, Lahore-54000, Punjab, Pakistan.

出版信息

Future Sci OA. 2024 May 15;10(1):FSO917. doi: 10.2144/fsoa-2023-0112. eCollection 2024.

DOI:10.2144/fsoa-2023-0112
PMID:38827795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11140666/
Abstract

To investigate the role of phosphorylation in SARS-CoV-2 infection, potential therapeutic targets and its harmful genetic sequences. Data mining techniques were employed to identify upregulated kinases responsible for proteomic changes induced by SARS-CoV-2. Spike and nucleocapsid proteins' sequences were analyzed using predictive tools, including SNAP2, MutPred2, PhD-SNP, SNPs&Go, MetaSNP, Predict-SNP and PolyPhen-2. Missense variants were identified using ensemble-based algorithms and homology/structure-based models like SIFT, PROVEAN, Predict-SNP and MutPred-2. Eight missense variants were identified in viral sequences. Four damaging variants were found, with SNPs&Go and PolyPhen-2. Promising therapeutic candidates, including gilteritinib, pictilisib, sorafenib, RO5126766 and omipalisib, were identified. This research offers insights into SARS-CoV-2 pathogenicity, highlighting potential treatments and harmful variants in viral proteins.

摘要

为了研究磷酸化在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染、潜在治疗靶点及其有害基因序列中的作用。采用数据挖掘技术来识别导致SARS-CoV-2诱导的蛋白质组变化的上调激酶。使用包括SNAP2、MutPred2、PhD-SNP、SNPs&Go、MetaSNP、Predict-SNP和PolyPhen-2在内的预测工具分析刺突蛋白和核衣壳蛋白的序列。使用基于集成的算法以及基于同源性/结构的模型(如SIFT、PROVEAN、Predict-SNP和MutPred-2)来识别错义变体。在病毒序列中鉴定出八个错义变体。使用SNPs&Go和PolyPhen-2发现了四个有害变体。确定了有前景的治疗候选药物,包括吉列替尼、匹西利司、索拉非尼、RO5126766和奥米帕利司。这项研究为SARS-CoV-2的致病性提供了见解,突出了病毒蛋白中的潜在治疗方法和有害变体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b7/11140666/dabf4184955f/IFSO_A_2341478_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b7/11140666/dabf4184955f/IFSO_A_2341478_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b7/11140666/dabf4184955f/IFSO_A_2341478_F0001_B.jpg

相似文献

1
SARS-CoV-2-induced phosphorylation and its pharmacotherapy backed by artificial intelligence and machine learning.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱导的磷酸化及其基于人工智能和机器学习的药物治疗。
Future Sci OA. 2024 May 15;10(1):FSO917. doi: 10.2144/fsoa-2023-0112. eCollection 2024.
2
Taxonium, a web-based tool for exploring large phylogenetic trees.Taxonium,一个用于探索大型系统发育树的网络工具。
Elife. 2022 Nov 15;11:e82392. doi: 10.7554/eLife.82392.
3
Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.揭示 SARS-CoV-2 刺突蛋白变体对人类受体的影响:一种分子动力学对接和模拟方法。
J Infect Public Health. 2023 Oct;16(10):1544-1555. doi: 10.1016/j.jiph.2023.07.011. Epub 2023 Jul 24.
4
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.通过 SARS-CoV-2 刺突蛋白变体逃避中和抗体。
Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.
5
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
6
Differential mutation profile of SARS-CoV-2 proteins across deceased and asymptomatic patients.新冠病毒蛋白在死亡和无症状患者中的差异突变特征。
Chem Biol Interact. 2021 Sep 25;347:109598. doi: 10.1016/j.cbi.2021.109598. Epub 2021 Jul 23.
7
Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.生物数据挖掘和机器学习技术在检测和诊断新型冠状病毒 (COVID-19) 中的作用:系统评价。
J Med Syst. 2020 May 25;44(7):122. doi: 10.1007/s10916-020-01582-x.
8
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
9
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.单次免疫表达刺突蛋白和核衣壳蛋白的重组 ACAM2000 痘苗病毒可保护仓鼠免受 SARS-CoV-2 引起的临床疾病。
J Virol. 2022 May 11;96(9):e0038922. doi: 10.1128/jvi.00389-22. Epub 2022 Apr 12.
10
Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.基于特征 SNP 对 SARS-CoV-2 进化枝进行特征描述揭示了其持续进化。
Methods. 2022 Jul;203:282-296. doi: 10.1016/j.ymeth.2021.09.005. Epub 2021 Sep 20.

本文引用的文献

1
Potential Coronaviral Inhibitors of the Nucleocapsid Protein Identified In Silico and In Vitro from a Large Natural Product Library.通过计算机模拟和体外实验从大型天然产物库中鉴定出的潜在冠状病毒核衣壳蛋白抑制剂
Pharmaceuticals (Basel). 2022 Aug 24;15(9):1046. doi: 10.3390/ph15091046.
2
A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19.人工智能和基于网络的方法在新冠病毒药物再利用中的综合综述
Biomed Pharmacother. 2022 Sep;153:113350. doi: 10.1016/j.biopha.2022.113350. Epub 2022 Jun 28.
3
Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID-19.
反义核酸技术作为一种治疗冠状病毒感染的潜在策略:聚焦 COVID-19。
IET Nanobiotechnol. 2022 May;16(3):67-77. doi: 10.1049/nbt2.12079. Epub 2022 Mar 10.
4
SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics.SARS-CoV-2 感染触发磷酸化:抗 COVID-19 治疗的潜在靶点。
Front Immunol. 2022 Feb 17;13:829474. doi: 10.3389/fimmu.2022.829474. eCollection 2022.
5
Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures.高通量筛选抗 SARS-CoV-2 体外活性检测方法的建立与优化:对 5676 种已过临床一期的化合物结构的评估。
J Med Virol. 2022 Jul;94(7):3101-3111. doi: 10.1002/jmv.27683. Epub 2022 Mar 23.
6
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses.超大规模虚拟筛选鉴定出针对冠状病毒具有广谱活性的 SARS-CoV-2 主蛋白酶抑制剂。
J Am Chem Soc. 2022 Feb 23;144(7):2905-2920. doi: 10.1021/jacs.1c08402. Epub 2022 Feb 10.
7
Screening for Inhibitors of Main Protease in SARS-CoV-2: In Silico and In Vitro Approach Avoiding Peptidyl Secondary Amides.SARS-CoV-2 主蛋白酶抑制剂的筛选:避免肽基仲酰胺的计算和体外方法。
J Chem Inf Model. 2022 Jan 24;62(2):350-358. doi: 10.1021/acs.jcim.1c01087. Epub 2022 Jan 11.
8
Drug delivery systems for RNA therapeutics.RNA 治疗药物的递药系统。
Nat Rev Genet. 2022 May;23(5):265-280. doi: 10.1038/s41576-021-00439-4. Epub 2022 Jan 4.
9
Genomic characterization of SARS-CoV-2 and its association with clinical outcomes: a 1-year longitudinal study of the pandemic in Colombia.SARS-CoV-2 的基因组特征及其与临床结局的关系:哥伦比亚大流行的 1 年纵向研究。
Int J Infect Dis. 2022 Mar;116:91-100. doi: 10.1016/j.ijid.2021.12.326. Epub 2021 Dec 15.
10
High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor.高通量虚拟筛选和 SARS-CoV-2 主蛋白酶非共价抑制剂的验证。
J Chem Inf Model. 2022 Jan 10;62(1):116-128. doi: 10.1021/acs.jcim.1c00851. Epub 2021 Nov 18.